Clinical Efficacy of Ginkgo Biloba Extract in the Treatment of Alzheimer’s Disease
Condition(s):Alzheimer’sLast Updated:August 7, 2019Unknown status
Hide Studies Not Open or Pending
Condition(s):Alzheimer’sLast Updated:August 7, 2019Unknown status
Condition(s):Vitiligo VulgarisLast Updated:July 8, 2010Completed
Condition(s):SchizophreniaLast Updated:July 12, 2016Completed
Condition(s):Memory DeficitLast Updated:February 24, 2021Withdrawn
Condition(s):Mild Cognitive ImpairmentLast Updated:October 14, 2015Completed
Condition(s):Dementia; Alzheimer’s DiseaseLast Updated:March 14, 2013Completed
Condition(s):Motoric Cognitive Risk Syndrome; Mild Cognitive Impairment; Aging; Locomotive SyndromeLast Updated:December 9, 2021Recruiting
Condition(s):SchizophreniaLast Updated:February 28, 2022Completed
Condition(s):Primary Open Angle Glaucoma; Drug EffectLast Updated:April 6, 2020Unknown status
Condition(s):Randomized Controlled Trial; Ginkgo Biloba ExtractLast Updated:April 27, 2018Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.